Listed

Enveric Biosciences, Inc.: Form 10-K/A for the period ended Dec 31, 2016

Filed with the SEC on Apr 4, 2017 and accepted by EDGAR at Apr 3, 2017, 20:18 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2016-01-01 to 2016-12-31$36.1mus-gaap:Revenues
Cost of revenue12 months2016-01-01 to 2016-12-31$29.6mus-gaap:CostOfRevenue
Gross profit12 months2016-01-01 to 2016-12-31$6.5mus-gaap:GrossProfit
Research and development12 months2016-01-01 to 2016-12-31$55.1kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2016-01-01 to 2016-12-31−$5.4mus-gaap:OperatingIncomeLoss
Interest expense12 months2016-01-01 to 2016-12-31$751.1kus-gaap:InterestExpense
Income tax12 months2016-01-01 to 2016-12-31−$3.7mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2016-01-01 to 2016-12-31−$2.8mus-gaap:NetIncomeLoss
Diluted EPS12 months2016-01-01 to 2016-12-31−$0.21us-gaap:EarningsPerShareDiluted
Basic EPS12 months2016-01-01 to 2016-12-31−$0.21us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2016-01-01 to 2016-12-3113,068,597 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2016-01-01 to 2016-12-31−$2.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2016-12-31$1.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$10.1mus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$39.5mus-gaap:Assets
Current liabilitiesAt period end2016-12-31$12.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-12-31$27.8mus-gaap:Liabilities
Long-term debtAt period end2016-12-31$405.4kus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2016-12-31$1.5mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2016-12-31$11.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001079974-17-000131. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.